We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$215M
AUM Growth
+$5.12M
Cap. Flow
-$12.1M
Cap. Flow %
-5.65%
Top 10 Hldgs %
32.15%
Holding
71
New
17
Increased
13
Reduced
23
Closed
12

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$5.41M
2
RVTY icon
Revvity
RVTY
+$4.91M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.67M
4
HCA icon
HCA Healthcare
HCA
+$4.38M
5
ABT icon
Abbott
ABT
+$4.32M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$9.29M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.42M
3
GILD icon
Gilead Sciences
GILD
+$5.73M
4
AZN icon
AstraZeneca
AZN
+$4.22M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.03M

Sector Composition

Rank Sector Weight
1 Healthcare 95.5%
2 Financials 3.26%
3 Energy 1.24%
4 Consumer Staples 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
$7.71M 3.59%
55,000
+15,000
+38% +$2.14M
UNH icon
2
UnitedHealth
UNH
$337B
$7.38M 3.44%
45,000
– –
ELV icon
3
Elevance Health
ELV
$89.5B
$7.24M 3.37%
43,795
-6,205
-12% -$987K
HUM icon
4
Humana
HUM
$46.2B
$7.21M 3.36%
35,000
-3,382
-9% -$699K
CI icon
5
Cigna
CI
$74.1B
$7.11M 3.31%
48,504
-1,506
-3% -$222K
AET
6
DELISTED
Aetna Inc
AET
$7M 3.26%
54,900
-5,100
-9% -$640K
LLY icon
7
Eli Lilly
LLY
$1.01T
$6.73M 3.13%
80,000
+50,000
+167% +$4M
INCY icon
8
Incyte
INCY
$25.3B
$6.68M 3.11%
50,000
-5,000
-9% -$637K
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$6.06M 2.82%
50,000
-10,000
-17% -$1.29M
CELG
10
DELISTED
Celgene Corp
CELG
$5.91M 2.75%
47,500
-20,000
-30% -$2.39M
BAX icon
11
Baxter International
BAX
$12.2B
$5.71M 2.66%
+110,000
New +$5.41M
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$130B
$5.47M 2.55%
50,000
+10,000
+25% +$880K
UHS icon
13
Universal Health Services
UHS
$10.7B
$5.29M 2.46%
42,500
+7,500
+21% +$886K
RVTY icon
14
Revvity
RVTY
$16.3B
$5.22M 2.43%
+90,000
New +$4.91M
BSX icon
15
Boston Scientific
BSX
$63.6B
$4.97M 2.32%
200,000
+25,000
+14% +$608K
ZBH icon
16
Zimmer Biomet
ZBH
$18.5B
$4.88M 2.27%
+41,200
New +$4.67M
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$12.5B
$4.83M 2.25%
55,000
-5,000
-8% -$445K
MRK icon
18
Merck
MRK
$358B
$4.77M 2.22%
78,600
-41,920
-35% -$2.54M
A icon
19
Agilent Technologies
A
$43.3B
$4.76M 2.22%
90,000
+55,000
+157% +$2.78M
HCA icon
20
HCA Healthcare
HCA
$93.2B
$4.67M 2.18%
+52,500
New +$4.38M
CNC icon
21
Centene
CNC
$32.6B
$4.63M 2.16%
130,000
-120,000
-48% -$4.02M
MCK icon
22
McKesson
MCK
$103B
$4.45M 2.07%
30,000
-5,000
-14% -$732K
ABT icon
23
Abbott
ABT
$177B
$4.44M 2.07%
+100,000
New +$4.32M
GWPH
24
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.26M 1.98%
35,200
+7,500
+27% +$920K
BMY icon
25
Bristol-Myers Squibb
BMY
$130B
$4.21M 1.96%
77,400
-47,600
-38% -$2.61M
1
2 3

Similar funds

NI
Nest Investments Conshohocken, Pennsylvania $132M AUM
KF
Kelsey Financial Moorpark, California $132M AUM
KCWM
Kane Co Wealth Management Johnston, Iowa $132M AUM
TWM
Tortuga Wealth Management Torrance, California $132M AUM
FB
Finward Bancorp Munster, Indiana $132M AUM 22.33% 1-Year Est. Return
QC
Quantedge Capital Singapore $132M AUM 56.43% 1-Year Est. Return
FCM
Floyd Capital Management Texarkana, Texas $132M AUM 20.87% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Sivik Global Healthcare's Q1 2017 Portfolio in Review

As of Q1 2017, Sivik Global Healthcare held 71 positions worth $215M, up 2.4% from $210M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Sivik Global Healthcare withdrew a net $12.1M in Q1 2017, closing 12 positions and reducing 23 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $9.29M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 89% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Baxter International worth $5.71M.

  • Sivik Global Healthcare's largest Q1 2017 buy was Baxter International: 110,000 shares worth $5.71M.
  • Sivik Global Healthcare added most to Eli Lilly in Q1 2017, an estimated $4M increase.
  • Sivik Global Healthcare's biggest Q1 2017 reduction was AstraZeneca, cutting an estimated $4.22M.
  • Sivik Global Healthcare fully exited iShares Biotechnology ETF in Q1 2017, selling an estimated $9.29M.
  • Sivik Global Healthcare's ten largest holdings make up 32% of its $215M portfolio in Q1 2017.
  • Sivik Global Healthcare opened 17 new positions and closed 12 in Q1 2017.
  • Sivik Global Healthcare's portfolio value rose 2.4% quarter-over-quarter to $215M.

Based on Sivik Global Healthcare's 13F filing for Q1 2017, filed 11 May 2017.